PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2015

Conditions
Peripheral Arterial Disease
Interventions
PROCEDURE

PacLitaxel Eluting Balloon Application

Stenting is a standard of care in revascularization for superficial femoral artery (SFA) atherosclerotic lesions. However, the Achilles' heel of this technique remains in-stent restenosis (ISR). While most of local therapies have failed to demonstrate significant benefit, studies for the treatment of SFA ISR are lacking and percutaneous transluminal angioplasty remains the current standard of care for this indication. Recent studies have shown successful results of drug eluting balloon in the treatment of SFA de-novo lesions and of coronary ISR.

Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01587482 - PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis | Biotech Hunter | Biotech Hunter